Announced Sat, 17 Jan · 18:52 IST

Colinz Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2026 ,inter alia, to consider and approve This is to inform the exchange ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Colinz Laboratories Ltd has informed BSE that its Board of Directors will meet on Saturday, 24 January 2026 at 3:30 PM at its registered office in Mumbai. The main agenda is to consider, approve, and take on record the Un-Audited Financial Results for the quarter ended 31 December 2025 (Q3 FY26). The company also reiterated that the trading window for designated persons and their immediate relatives, which closed on 1 January 2026, will reopen 48 hours after the results are declared. No financial figures or other agenda items have been disclosed in this notice.

Likely market impact

This is a routine compliance filing ahead of quarterly results. Investors should watch for the Q3 FY26 numbers on or after 24 January 2026, which could move the stock once declared.